Prospective evaluation of the characteristics and incidence of adenoma-associated dural invasion in Cushing disease

Russell R. Lonser, Alexander Ksendzovsky, Joshua J. Wind, Alexander Vortmeyer, Edward H. Oldfield

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Object. Dural invasion by adrenocorticotropic hormone (ACTH)-secreting adenomas is a significant risk factor for incomplete resection and recurrence in Cushing disease (CD). Since ACTH-producing adenomas are often the smallest of the various types of pituitary tumors at the time of resection, examining their invasion provides the best opportunity to identify the precise sites of early dural invasion by pituitary adenomas. To characterize the incidence and anatomical distribution of dural invasion by ACTH-secreting adenomas, the authors prospectively and systematically analyzed features of dural invasion in patients with CD. Methods. The authors prospectively studied consecutive patients with CD undergoing the systematic removal of ACTH-secreting adenoma and histological analysis of the anterior sella dura as well as other sites of dural invasion that were evident at surgery. Clinical, imaging, histological, and operative findings were analyzed. Results. Eighty-seven patients with CD (58 females and 29 males) were included in the study. Overall, dural invasion by an ACTH-positive adenoma was histologically confirmed in 30 patients (34%). Eighteen patients (60% of dural invasion cases, 21% of all patients) had evidence of cavernous sinus wall invasion (4 of these patients also had other contiguous sites of invasion), and 12 patients (40% of dural invasion cases) had invasion of the sella dura excluding the cavernous sinus wall. Eleven patients (13% all patients) had invasion of the routinely procured anterior sella dura specimen. Preoperative MR imaging revealed an adenoma in 64 patients (74%) but accurately predicted dural invasion in only 4 patients (22%) with cavernous sinus invasion and none of the patients with non-cavernous sinus invasion. Adenomas associated with dural invasion (mean ± SD, 10.9 ± 7.8 mm, range 2-37 mm) were significantly larger than those not associated with dural invasion (5.7 ± 2.1 mm, range 2.5-12 mm; p = 0.0006, Mann- Whitney test). Conclusions. Dural invasion by ACTH-producing adenomas preferentially occurs laterally into the wall of the cavernous sinus. Preoperative MR imaging infrequently detects dural invasion, including cavernous sinus invasion. Invasion is directly associated with tumor size. To provide a biochemical cure and avoid recurrence after resection, identification and removal of invaded sella dura, including the medial cavernous sinus wall, are necessary.

Original languageEnglish (US)
Pages (from-to)272-279
Number of pages8
JournalJournal of neurosurgery
Volume116
Issue number2
DOIs
StatePublished - Feb 1 2012
Externally publishedYes

Fingerprint

Pituitary ACTH Hypersecretion
Adenoma
Cavernous Sinus
Incidence
Adrenocorticotropic Hormone
Pituitary Neoplasms
Recurrence

Keywords

  • Adenoma
  • Cavernous sinus
  • Cushing disease
  • Dura
  • Invasion
  • Pituitary surgery

ASJC Scopus subject areas

  • Surgery
  • Medicine(all)
  • Clinical Neurology

Cite this

Prospective evaluation of the characteristics and incidence of adenoma-associated dural invasion in Cushing disease. / Lonser, Russell R.; Ksendzovsky, Alexander; Wind, Joshua J.; Vortmeyer, Alexander; Oldfield, Edward H.

In: Journal of neurosurgery, Vol. 116, No. 2, 01.02.2012, p. 272-279.

Research output: Contribution to journalArticle

Lonser, Russell R. ; Ksendzovsky, Alexander ; Wind, Joshua J. ; Vortmeyer, Alexander ; Oldfield, Edward H. / Prospective evaluation of the characteristics and incidence of adenoma-associated dural invasion in Cushing disease. In: Journal of neurosurgery. 2012 ; Vol. 116, No. 2. pp. 272-279.
@article{17dd13c731d94c4880d67ccdf9ed829f,
title = "Prospective evaluation of the characteristics and incidence of adenoma-associated dural invasion in Cushing disease",
abstract = "Object. Dural invasion by adrenocorticotropic hormone (ACTH)-secreting adenomas is a significant risk factor for incomplete resection and recurrence in Cushing disease (CD). Since ACTH-producing adenomas are often the smallest of the various types of pituitary tumors at the time of resection, examining their invasion provides the best opportunity to identify the precise sites of early dural invasion by pituitary adenomas. To characterize the incidence and anatomical distribution of dural invasion by ACTH-secreting adenomas, the authors prospectively and systematically analyzed features of dural invasion in patients with CD. Methods. The authors prospectively studied consecutive patients with CD undergoing the systematic removal of ACTH-secreting adenoma and histological analysis of the anterior sella dura as well as other sites of dural invasion that were evident at surgery. Clinical, imaging, histological, and operative findings were analyzed. Results. Eighty-seven patients with CD (58 females and 29 males) were included in the study. Overall, dural invasion by an ACTH-positive adenoma was histologically confirmed in 30 patients (34{\%}). Eighteen patients (60{\%} of dural invasion cases, 21{\%} of all patients) had evidence of cavernous sinus wall invasion (4 of these patients also had other contiguous sites of invasion), and 12 patients (40{\%} of dural invasion cases) had invasion of the sella dura excluding the cavernous sinus wall. Eleven patients (13{\%} all patients) had invasion of the routinely procured anterior sella dura specimen. Preoperative MR imaging revealed an adenoma in 64 patients (74{\%}) but accurately predicted dural invasion in only 4 patients (22{\%}) with cavernous sinus invasion and none of the patients with non-cavernous sinus invasion. Adenomas associated with dural invasion (mean ± SD, 10.9 ± 7.8 mm, range 2-37 mm) were significantly larger than those not associated with dural invasion (5.7 ± 2.1 mm, range 2.5-12 mm; p = 0.0006, Mann- Whitney test). Conclusions. Dural invasion by ACTH-producing adenomas preferentially occurs laterally into the wall of the cavernous sinus. Preoperative MR imaging infrequently detects dural invasion, including cavernous sinus invasion. Invasion is directly associated with tumor size. To provide a biochemical cure and avoid recurrence after resection, identification and removal of invaded sella dura, including the medial cavernous sinus wall, are necessary.",
keywords = "Adenoma, Cavernous sinus, Cushing disease, Dura, Invasion, Pituitary surgery",
author = "Lonser, {Russell R.} and Alexander Ksendzovsky and Wind, {Joshua J.} and Alexander Vortmeyer and Oldfield, {Edward H.}",
year = "2012",
month = "2",
day = "1",
doi = "10.3171/2011.8.JNS11456",
language = "English (US)",
volume = "116",
pages = "272--279",
journal = "Journal of Neurosurgery",
issn = "0022-3085",
publisher = "American Association of Neurological Surgeons",
number = "2",

}

TY - JOUR

T1 - Prospective evaluation of the characteristics and incidence of adenoma-associated dural invasion in Cushing disease

AU - Lonser, Russell R.

AU - Ksendzovsky, Alexander

AU - Wind, Joshua J.

AU - Vortmeyer, Alexander

AU - Oldfield, Edward H.

PY - 2012/2/1

Y1 - 2012/2/1

N2 - Object. Dural invasion by adrenocorticotropic hormone (ACTH)-secreting adenomas is a significant risk factor for incomplete resection and recurrence in Cushing disease (CD). Since ACTH-producing adenomas are often the smallest of the various types of pituitary tumors at the time of resection, examining their invasion provides the best opportunity to identify the precise sites of early dural invasion by pituitary adenomas. To characterize the incidence and anatomical distribution of dural invasion by ACTH-secreting adenomas, the authors prospectively and systematically analyzed features of dural invasion in patients with CD. Methods. The authors prospectively studied consecutive patients with CD undergoing the systematic removal of ACTH-secreting adenoma and histological analysis of the anterior sella dura as well as other sites of dural invasion that were evident at surgery. Clinical, imaging, histological, and operative findings were analyzed. Results. Eighty-seven patients with CD (58 females and 29 males) were included in the study. Overall, dural invasion by an ACTH-positive adenoma was histologically confirmed in 30 patients (34%). Eighteen patients (60% of dural invasion cases, 21% of all patients) had evidence of cavernous sinus wall invasion (4 of these patients also had other contiguous sites of invasion), and 12 patients (40% of dural invasion cases) had invasion of the sella dura excluding the cavernous sinus wall. Eleven patients (13% all patients) had invasion of the routinely procured anterior sella dura specimen. Preoperative MR imaging revealed an adenoma in 64 patients (74%) but accurately predicted dural invasion in only 4 patients (22%) with cavernous sinus invasion and none of the patients with non-cavernous sinus invasion. Adenomas associated with dural invasion (mean ± SD, 10.9 ± 7.8 mm, range 2-37 mm) were significantly larger than those not associated with dural invasion (5.7 ± 2.1 mm, range 2.5-12 mm; p = 0.0006, Mann- Whitney test). Conclusions. Dural invasion by ACTH-producing adenomas preferentially occurs laterally into the wall of the cavernous sinus. Preoperative MR imaging infrequently detects dural invasion, including cavernous sinus invasion. Invasion is directly associated with tumor size. To provide a biochemical cure and avoid recurrence after resection, identification and removal of invaded sella dura, including the medial cavernous sinus wall, are necessary.

AB - Object. Dural invasion by adrenocorticotropic hormone (ACTH)-secreting adenomas is a significant risk factor for incomplete resection and recurrence in Cushing disease (CD). Since ACTH-producing adenomas are often the smallest of the various types of pituitary tumors at the time of resection, examining their invasion provides the best opportunity to identify the precise sites of early dural invasion by pituitary adenomas. To characterize the incidence and anatomical distribution of dural invasion by ACTH-secreting adenomas, the authors prospectively and systematically analyzed features of dural invasion in patients with CD. Methods. The authors prospectively studied consecutive patients with CD undergoing the systematic removal of ACTH-secreting adenoma and histological analysis of the anterior sella dura as well as other sites of dural invasion that were evident at surgery. Clinical, imaging, histological, and operative findings were analyzed. Results. Eighty-seven patients with CD (58 females and 29 males) were included in the study. Overall, dural invasion by an ACTH-positive adenoma was histologically confirmed in 30 patients (34%). Eighteen patients (60% of dural invasion cases, 21% of all patients) had evidence of cavernous sinus wall invasion (4 of these patients also had other contiguous sites of invasion), and 12 patients (40% of dural invasion cases) had invasion of the sella dura excluding the cavernous sinus wall. Eleven patients (13% all patients) had invasion of the routinely procured anterior sella dura specimen. Preoperative MR imaging revealed an adenoma in 64 patients (74%) but accurately predicted dural invasion in only 4 patients (22%) with cavernous sinus invasion and none of the patients with non-cavernous sinus invasion. Adenomas associated with dural invasion (mean ± SD, 10.9 ± 7.8 mm, range 2-37 mm) were significantly larger than those not associated with dural invasion (5.7 ± 2.1 mm, range 2.5-12 mm; p = 0.0006, Mann- Whitney test). Conclusions. Dural invasion by ACTH-producing adenomas preferentially occurs laterally into the wall of the cavernous sinus. Preoperative MR imaging infrequently detects dural invasion, including cavernous sinus invasion. Invasion is directly associated with tumor size. To provide a biochemical cure and avoid recurrence after resection, identification and removal of invaded sella dura, including the medial cavernous sinus wall, are necessary.

KW - Adenoma

KW - Cavernous sinus

KW - Cushing disease

KW - Dura

KW - Invasion

KW - Pituitary surgery

UR - http://www.scopus.com/inward/record.url?scp=84856768887&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856768887&partnerID=8YFLogxK

U2 - 10.3171/2011.8.JNS11456

DO - 10.3171/2011.8.JNS11456

M3 - Article

C2 - 21923247

AN - SCOPUS:84856768887

VL - 116

SP - 272

EP - 279

JO - Journal of Neurosurgery

JF - Journal of Neurosurgery

SN - 0022-3085

IS - 2

ER -